Back to Atlas
CTransientStandard research/education caution
CMP-0464
Approved in some countries
Tibolone
Endocrine / Steroid hormone modulator
Menopause therapy; not a muscle-building AAS
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Synthetic steroid
- Primary mechanism
- Tissue-selective estrogenic/progestogenic/androgenic metabolites; A:A ratio N/A
- Primary market use
- Menopausal hormone therapy
Pharmacology
- Molecular weight (Da)
- 312.45
- Oral bioavailability
- Oral; clinically active
- Half-life
- ~45 h metabolites/overall effect
- Route tags
- Route-dependent / verify
- Evidence level
- Approved
- Clinical status
- Approved in some countries
- Value-for-money score
- 4 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Included because WADA lists it under anabolic agents; classify as endocrine steroid, not anabolic-builder.